Business · 11/09/2023
FDA Releases Draft Guidance on Clinical Pharmacology Considerations for Peptide Drug Products
The FDA has announced the availability of a draft guidance for industry on clinical pharmacology considerations for peptide drug product development programs, aiming to assist industry in conducting these programs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →